1. Home
  2. Labeler Index
  3. Amgen Inc
  4. 55513-078
  5. Product Images: Imlygic

Product Images Imlygic

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Imlygic NDC 55513-078 by Amgen Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Injection administration for cutaneous lesions - imlygic 01

Figure 1: Injection administration for cutaneous lesions - imlygic 01

Figure 2: Injection administration for subcutaneous lesions - imlygic 02

Figure 2: Injection administration for subcutaneous lesions - imlygic 02

Figure 3: Injection administration for nodal lesions - imlygic 03

Figure 3: Injection administration for nodal lesions - imlygic 03

Figure 4: Single-use vial permanently inserted into a clear copolyester plastic sleeve - imlygic 04

Figure 4: Single-use vial permanently inserted into a clear copolyester plastic sleeve - imlygic 04

Figure 5: Single-use vial without a clear plastic sleeve - imlygic 05

Figure 5: Single-use vial without a clear plastic sleeve - imlygic 05

imlygic 06

imlygic 06

This is a description of a medication called IMLYGIC, which comes in a 10¢ PFU/mL Single Use Vial consisting of 1 mL of deliverable containing 10 plaque forming units (PFU), meant for intralesional injection. It is a Suspension for Injection made of lumefantrine and d-sodium bydrogen phosphate dihydrate, with no preservatives and packaged in a natural rubber latex-free container. The text also provides storage instructions for this medication.*

Principal Display PanelStore at -70⁰C to -90⁰C (-94⁰F to -130⁰F)talimogene laherparepvec106 PFU/mL106 PFU/mLFor Intralesional Injection OnlyBioVex, Inc., a subsidiary of Amgen Inc.,One Amgen Center Drive, Thousand Oaks, California 91320-1799Rx OnlyLot:Exp.: - imlygic 07

Principal Display PanelStore at -70⁰C to -90⁰C (-94⁰F to -130⁰F)talimogene laherparepvec106 PFU/mL106 PFU/mLFor Intralesional Injection OnlyBioVex, Inc., a subsidiary of Amgen Inc.,One Amgen Center Drive, Thousand Oaks, California 91320-1799Rx OnlyLot:Exp.: - imlygic 07

This appears to be a medication guide and package insert for a drug called IMLYGIC®. It is a suspension for injection containing talimogene laherparepvec at a concentration of 10 PFU/mL and 10 PRU/mL in a single-use vial. The drug is not meant to be diluted and must be stored at a certain temperature range. Detailed prescription information and instructions are available in the package insert.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.